MAPLE GROVE, Minn., Feb. 2 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. is pleased to announce the introduction of a new formulation of PreNexa® Rx prenatal vitamins. The new formulation contains an increased amount of algal-oil, plant-based docosahexaenoic acid (DHA), from 265 mg to 300 mg and increased vitamin D3, from 170 IU to 400 IU.(1)
DHA, a key omega-3 fatty acid used throughout the body, helps support fetal and infant brain and eye development.(2,3) Vitamin D is an essential vitamin for mom's and baby's skeletal health.(4)
"PreNexa® is the fastest growing single-capsule prenatal vitamin with plant-based DHA on the market. This new formulation reflects the increasing body of evidence pointing to the important role DHA and vitamin D play in pregnancy, lactation and infancy," said Wesley Mark Todd, MD, Senior Director Medical Affairs, Upsher-Smith Laboratories, Inc.
The NDC number for the new formulation of PreNexa® is 0245-0177-30. Key product features remain the same, including: the bottle configuration, amount per bottle (30 gel capsules), look of the gel capsule, and regimen of one pill once daily.
Important Safety Information
Please see full Prescribing Information for a complete list of warnings and precautions. Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
Upsher-Smith Laboratories, Inc. is a rapidly growing pharmaceutical company that manufactures and markets both prescription and consumer products. Privately held since 1919, the company striv
|SOURCE Upsher-Smith Laboratories, Inc.|
Copyright©2010 PR Newswire.
All rights reserved